Italy's Money-Back Guarantee for Cancer Treatments
January 19, 2016.
Italy’s state-run health service is demanding a money-back guarantee when trying new cancer treatments, Bloomsberg Business reports. The Italian Medicines Agency will pay pharma companies according to how well a patient responds to treatment. In some cases, where the medication fails to help, the drugmaker must provide a full refund. Through this method, approximately 200 million euros ($220 million) was refunded to the Italian government for ineffective treatments last year, amounting to about 1 percent of total pharmaceutical spending. With global oncology expected to reach $100 billion in 2018, Bloomsberg adds that Italy's money-back experiment is being monitored in the U.S. and across Europe. http://www.bloomberg.com/news/articles/2016-01-15/when-new-cancer-treatments-fail-italy-wants-its-money-back
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
